印度肿瘤测试市场每年增长2%, 受癌症病例增加和创新推动。 India's oncology tests market grows 2% annually, driven by rising cancer cases and innovation.

印度肿瘤测试市场预计到2033年每年增长约2%, 原因是生活方式改变、环境因素、人口老化导致癌症病例增加。 India's oncology tests market is expected to grow at about 2% annually through 2033, driven by rising cancer cases from lifestyle changes, environmental factors, and an aging population. 印度目前拥有亚洲-太平洋肿瘤测试市场的3%以上。 India currently holds over 3% of the Asia-Pacific oncology tests market. 尽管在获得治疗和负担能力等方面面临挑战,但该国力求通过创新的解决办法和研究,包括新的早期癌症检测血液测试,加强医疗保健。 Despite challenges like access and affordability, the country aims to enhance healthcare through innovative solutions and research, including a new blood test for early cancer detection.